Northern Trust’s Replimune Group REPL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.51M Buy
589,120
+49,520
+9% +$379K ﹤0.01% 2508
2025
Q4
$5.24M Sell
539,600
-74,593
-12% -$634K ﹤0.01% 2444
2025
Q3
$2.57M Buy
614,193
+27,426
+5% +$175K ﹤0.01% 2889
2025
Q2
$5.45M Sell
586,767
-46,229
-7% -$403K ﹤0.01% 2421
2025
Q1
$6.17M Buy
632,996
+43,361
+7% +$537K ﹤0.01% 2308
2024
Q4
$7.14M Buy
589,635
+40,134
+7% +$488K ﹤0.01% 2315
2024
Q3
$6.02M Buy
549,501
+86,242
+19% +$876K ﹤0.01% 2368
2024
Q2
$4.17M Sell
463,259
-20,385
-4% -$142K ﹤0.01% 2497
2024
Q1
$3.95M Buy
483,644
+1,810
+0.4% +$14.8K ﹤0.01% 2610
2023
Q4
$4.06M Buy
481,834
+29,091
+6% +$337K ﹤0.01% 2624
2023
Q3
$7.75M Buy
452,743
+40,901
+10% +$803K ﹤0.01% 2169
2023
Q2
$9.56M Sell
411,842
-33,911
-8% -$663K ﹤0.01% 2103
2023
Q1
$7.87M Buy
445,753
+39,818
+10% +$947K ﹤0.01% 2178
2022
Q4
$11M Buy
405,935
+21,143
+5% +$439K ﹤0.01% 1934
2022
Q3
$6.64M Buy
384,792
+71,086
+23% +$1.36M ﹤0.01% 2274
2022
Q2
$5.48M Buy
313,706
+11,872
+4% +$195K ﹤0.01% 2446
2022
Q1
$5.13M Sell
301,834
-1,299
-0.4% -$24.5K ﹤0.01% 2574
2021
Q4
$8.21M Sell
303,133
-76,555
-20% -$2.29M ﹤0.01% 2379
2021
Q3
$11.3M Buy
379,688
+5,449
+1% +$177K ﹤0.01% 2187
2021
Q2
$14.4M Buy
374,239
+81,548
+28% +$2.79M ﹤0.01% 2122
2021
Q1
$8.93M Sell
292,691
-23,567
-7% -$883K ﹤0.01% 2366
2020
Q4
$12.1M Buy
316,258
+30,442
+11% +$1.27M ﹤0.01% 2136
2020
Q3
$6.58M Buy
285,816
+42,531
+17% +$969K ﹤0.01% 2368
2020
Q2
$6.05M Buy
243,285
+77,844
+47% +$1.38M ﹤0.01% 2401
2020
Q1
$1.65M Buy
165,441
+16,411
+11% +$245K ﹤0.01% 2962
2019
Q4
$2.14M Buy
149,030
+24,816
+20% +$358K ﹤0.01% 3095
2019
Q3
$1.73M Buy
124,214
+283
+0.2% +$3.47K ﹤0.01% 3181
2019
Q2
$1.82M Buy
123,931
+1,437
+1% +$20.8K ﹤0.01% 3126
2019
Q1
$1.86M Buy
122,494
+41,260
+51% +$514K ﹤0.01% 3125
2018
Q4
$813K Buy
81,234
+2,014
+3% +$27.2K ﹤0.01% 3428
2018
Q3
$1.27M Buy
+79,220
New +$1.39M ﹤0.01% 3402

Other funds holding REPL

Northern Trust's REPL Position: Q1 2026 in Review

Northern Trust increased its Replimune Group (REPL) stake by 9.2% in Q1 2026, buying an estimated $379K and bringing the position to 589,120 shares worth $4.51M. The position accounts for ﹤0.01% of the portfolio, ranked #2508.

Northern Trust first reported a position in REPL in Q3 2018 and has held it in 31 quarters since. The position peaked at $14.4M in Q2 2021. 180 funds tracked by Wall St. Rank hold REPL as of Q1 2026.

  • Northern Trust held 589,120 shares of Replimune Group worth $4.51M as of Q1 2026.
  • Northern Trust bought 49,520 Replimune Group shares in Q1 2026, an estimated $379K.
  • Replimune Group made up ﹤0.01% of Northern Trust's portfolio in Q1 2026, its #2508 holding.
  • Northern Trust first reported a position in Replimune Group in Q3 2018 and has held it in 31 quarters since.
  • Northern Trust's Replimune Group position peaked at $14.4M in Q2 2021.
  • 180 funds tracked by Wall St. Rank held Replimune Group as of Q1 2026.

Based on Northern Trust's 13F filing for Q1 2026, filed 14 May 2026.